MAPT and Alzheimer disease: Thus, while several pathologically significant protein-based CSF biomarkers such as amyloid-b (Ab42), total tau (T-tau), and phosphorylated tau (P-tau) have been traditionally used for AD diagnostics, cellular CSF biomarkers may provide novel insights into the immune responses [50].